Anti-SEM3D/ SEMA3D/ Sema-Z2 functional antibody

Anti-SEM3D/ SEMA3D/ Sema-Z2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SEMA3D/SEMA3D products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0461-Ab-1/ GM-Tg-hg-SE0461-Ab-2Anti-Human SEMA3D monoclonal antibodyHuman
GM-Tg-rg-SE0461-Ab-1/ GM-Tg-rg-SE0461-Ab-2Anti-Rat SEMA3D monoclonal antibodyRat
GM-Tg-mg-SE0461-Ab-1/ GM-Tg-mg-SE0461-Ab-2Anti-Mouse SEMA3D monoclonal antibodyMouse
GM-Tg-cynog-SE0461-Ab-1/ GM-Tg-cynog-SE0461-Ab-2Anti-Cynomolgus/ Rhesus macaque SEMA3D monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0461-Ab-1/ GM-Tg-felg-SE0461-Ab-2Anti-Feline SEMA3D monoclonal antibodyFeline
GM-Tg-cang-SE0461-Ab-1/ GM-Tg-cang-SE0461-Ab-2Anti-Canine SEMA3D monoclonal antibodyCanine
GM-Tg-bovg-SE0461-Ab-1/ GM-Tg-bovg-SE0461-Ab-2Anti-Bovine SEMA3D monoclonal antibodyBovine
GM-Tg-equg-SE0461-Ab-1/ GM-Tg-equg-SE0461-Ab-2Anti-Equine SEMA3D monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0461-Ab-1/ GM-Tg-hg-SE0461-Ab-2; GM-Tg-rg-SE0461-Ab-1/ GM-Tg-rg-SE0461-Ab-2;
GM-Tg-mg-SE0461-Ab-1/ GM-Tg-mg-SE0461-Ab-2; GM-Tg-cynog-SE0461-Ab-1/ GM-Tg-cynog-SE0461-Ab-2;
GM-Tg-felg-SE0461-Ab-1/ GM-Tg-felg-SE0461-Ab-2; GM-Tg-cang-SE0461-Ab-1/ GM-Tg-cang-SE0461-Ab-2;
GM-Tg-bovg-SE0461-Ab-1/ GM-Tg-bovg-SE0461-Ab-2; GM-Tg-equg-SE0461-Ab-1/ GM-Tg-equg-SE0461-Ab-2
Products NameAnti-SEMA3D monoclonal antibody
Formatmab
Target NameSEMA3D
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SEMA3D benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0461-Ag-1Recombinant multi-species SEM3D/ SEMA3D/ Sema-Z2 protein


    Target information

    Target IDGM-SE0461
    Target NameSEMA3D
    Gene ID223117,108151,246262,707146,475929,101095091,536417,100058327
    Gene Symbol and Synonyms4631426B19Rik,coll-2,Sema-Z2,SEMA3D
    Uniprot AccessionO95025
    Uniprot Entry NameSEM3D_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000153993
    Target ClassificationN/A

    The target: SEMA3D, gene name: SEMA3D, also named as Sema-Z2, coll-2. This gene encodes a member of the semaphorin III family of secreted signaling proteins that are involved in axon guidance during neuronal development. The encoded protein contains an N-terminal Sema domain, an immunoglobulin like domain and a C-terminal basic domain. The protein encoded by this gene binds neuropilin and plays an important role in cardiovascular development. [provided by RefSeq, Aug 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.